IMUNON Announces IMNN-001 Abstract Accepted for Oral Presentation at 2025 ASCO Annual Meeting

• click to rate

  Posted by Two Blokes Apr 21 - Filed in Stock - 2 views
  
  Highly promising survival data from OVATION 2 Study of treatment of newly diagnosed advanced ovarian cancer to be presented